诊股

大数据帮您全面分析股票

Description

【诊股APP】从萝卜投研中挑选了利用大数据对个股进行全方位分析形成诊断报告的子功能,供用户进行投资参考;
【萝卜投研】是通联数据旗下,基于大数据和机器学习的智能投研平台。利用人工智能、大数据、移动应用技术,建立开放、分享、高效的基本面投研平台,满足用户在证券研究过程中高效处理信息、快速挖掘投资线索的迫切需求。同时使得碎片化的研究成果得以沉淀积累,构建投研核心竞争力,为投资决策提供重要支持。是通联数据为“基本面投资者”量身打造的一款智能投资研究工具。
【通联数据股份公司(Datayes)】是一家人工智能科技公司,以创新性的投资理念和技术,引领投资管理行业进入智能投资导航时代。通联数据洞察资产管理行业未来发展趋势,致力于将人工智能、大数据、云计算等信息技术和专业的投资理念相结合,打造下一代投资平台。多年来我们持续深耕实践,推出面向金融机构的萝卜投资、优矿,面向个人投资者的萝卜投研APP等产品,目前已服务于海内外2000+金融机构及10000000+个人投资者。
市场有风险,投资需谨慎
官方微信:robotouyan
服务热线:400-082-0386
反馈邮箱:[email protected]
官方网站:https://robo.tt
Hide Show More...

Screenshots

诊股 FAQ

  • Is 诊股 free?

    Yes, 诊股 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is 诊股 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 诊股 cost?

    诊股 is free.

  • What is 诊股 revenue?

    To get estimated revenue of 诊股 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in China yet.
Ratings History

诊股 Reviews

App doesn't have any reviews yet

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Keywords

诊股 Competitors

诊股 Installs

Last 30 days

诊股 Revenue

Last 30 days

诊股 Revenue and Downloads

Gain valuable insights into 诊股 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Finance
Languages
English
Recent release
1.0.0 (2 years ago )
Released on
Nov 24, 2022 (2 years ago )
Also available in
China
Last Updated
3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.